View More Recent Stories

May 6, 2016 07:30AM venBio Closes $315 Million Life Sciences Venture Capital Fund
Apr 29, 2016 05:47PM Form SC 13G Nabriva Therapeutics AG Filed by: venBio Global Strategic Fund II L.P.
Apr 20, 2016 01:05AM Checkmate Pharmaceuticals Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer and Announces Dosing of First Patient in Immuno-Oncology Phase 1b Trial with CMP-001, a TLR9 Agonist
Mar 15, 2016 08:00AM Heart Metabolics Announces Multiple Senior Appointments To Management Team
Feb 12, 2016 12:01PM Form 13F-HR venBio Select Advisor For: Dec 31
Feb 12, 2016 11:13AM Form SC 13G PERNIX THERAPEUTICS HOLD Filed by: venBio Select Advisor LLC
Feb 12, 2016 11:12AM Form SC 13G Mirati Therapeutics, Filed by: venBio Select Advisor LLC
Feb 12, 2016 11:11AM Form SC 13G Lion Biotechnologies, Filed by: venBio Select Advisor LLC
Feb 12, 2016 06:00AM Apellis Completes $47 Million Series D Financing
Jan 12, 2016 05:23PM PlacementTracker Publishes 2015 PIPE Market League Tables
Nov 13, 2015 12:28PM Form 13F-HR venBio Select Advisor For: Sep 30
Oct 14, 2015 03:50PM EY and SolomonEdwards honor the 2015 Venture Capital Award of Excellence winners
Oct 7, 2015 09:00AM PlacementTracker Publishes Third Quarter 2015 PIPE Market League Tables
Sep 29, 2015 08:00AM Oncobiologics Secures Financing from Sabby Management, LLC, to Advance BioSymphony™ Platform and Monoclonal Antibody Biosimilars Pipeline
Sep 29, 2015 08:00AM Corvus Pharmaceuticals Completes $75 Million Series B Financing
Aug 18, 2015 05:03PM venBio's New Biotech Bet is One to Watch
View More Recent Stories